Technetium-99m-labeled HOE 140: a potential bradykinin B2 receptor imaging agent.
Stahl
W
W
Zentrale Pharmaforschung, Radiochemisches Labor, and PGE Cardiovascular, Hoechst AG, Frankfurt, FRG.
Breipohl
G
G
Kuhlmann
L
L
Steinsträsser
A
A
Gerhards
H J
HJ
Schölkens
B A
BA
D000595:Amino Acid Sequence; D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D002614:Chelating Agents / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D005021:Ethylamines / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D006168:Guinea Pigs; D007553:Isotope Labeling / Q000379:methods; D008969:Molecular Sequence Data; D015609:Organotechnetium Compounds / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology*; D011877:Radionuclide Imaging; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000032:analysis* / Q000378:metabolism; D014018:Tissue Distribution
D002614:Chelating Agents; D005021:Ethylamines; D015609:Organotechnetium Compounds; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; C007143:2-(4-chlorophenylthio)triethylamine; C065679:icatibant; D001920:Bradykinin